Prof. Bairong Shen
Professor and director general of the Institutes for Systems Genetics at West China Hospital

Sichuan University, China

Bairong Shen received his PhD degree in Physical Chemistry from Fudan University in 1997. He began his research in bioinformatics in June 1999 and underwent postdoctoral training at the University of Tampere, Finland. Following that, he was recruited as an assistant/associate professor of systems biology in early 2004. In June 2008, he returned to China and established the Center for Systems Biology at Soochow University, where he served as the director. In the summer of 2018, he was appointed as a professor and the director general of the Institutes for Systems Genetics at West China Hospital, Sichuan University, China. Throughout the past 25 years, he has published over 300 scientific papers and 10 books. He has also served as a peer reviewer for more than 30 international journals and is an affiliated faculty member at the Institute for Systems Biology in Seattle. Additionally, he is the founding chair of the International Conference on Translational Informatics (ICTI). His research interests encompass biomarker discovery, translational informatics, and smart healthcare.

 

 

Prof. Yumei Li
Soochow University

 

Dr. Yumei Li received her bachelor’s degree from Nankai University in 2014 and her Ph.D. from Peking University in 2019. She then was appointed as a postdoctoral fellow at UC Irvine (2019–2022), supported by the George E. Hewitt Foundation for Medical Research. She is currently a professor at School of Basic Medicine, Soochow University. Her research focuses on transcriptomics and epigenomics, with particular interest in the development and application of bioinformatics approaches to study epigenetic regulation in both fundamental biological processes and disease pathogenesis. She has authored more than 20 publications in high-impact journals, including PNAS, Molecular Cell, and Genome Biology. Dr. Li is a member of the Omics Branch of the Chinese Stroke Association. She has been recognized as a Jiangsu Specially-Appointed Professor, and her work is supported by grants from the National Natural Science Foundation of China (NSFC) and the Natural Science Foundation of Jiangsu Province.

 

Assoc. Prof. Balachandran Manavalan
Sungkyunkwan University

 

Dr. Balachandran Manavalan is an Associate Professor in the Department of Integrative Biotechnology at Sungkyunkwan University (SKKU). His core research is at the intersection of AI applications with biology, environmental science and nanotechnology. His lab develops cutting-edge bioinformatics methods to identify biomarkers for early disease detection, prediction peptide therapeutic function and DNA/RNA modification sites, assess water toxicity, and protein corona formation. Dr. Manavalan has secured multi year grants from the National Research Foundation of Korea (NRF) and KHIDI. He has authored over 150 research articles. According to ScholarGPS, he is ranked among the top 20 scholars globally in both Peptides and Bioinformatics.

 

Speech Title: "Universal Prediction of RNA Modifications Across Mammals Using Hierarchical Transformers"

 

Abstract: RNA modifications represent critical post-transcriptional regulators of gene expression and immune cell function, acting as central components of the epi-transcriptomic landscape. These chemical marks modulate RNA stability, splicing, translation, and localization, with specific modification sites emerging as key contributors to human health and disease. Over the past eight years, we have developed several computational frameworks for the individual prediction of RNA modifications and contributed to the field through rigorous, unbiased benchmarking. However, single-modification prediction tools remain limited in practical utility. To address this limitation, we present HiFormer-RM, the first comprehensive framework for the simultaneous prediction of sixteen prominent human RNA modification types—including m⁶A, m⁵C, m⁷G, A-to-I, Ψ, m¹A, m⁶Am, Am, Gm, Cm, Um, m⁵U, ac⁴C, D, m²G, and m²,²G. HiFormer-RM leverages a hierarchical transformer architecture capable of learning both local sequence motifs and global contextual dependencies through multi-mer feature extraction. This enables robust and generalizable predictions across diverse sequence contexts. The results demonstrate that HiFormer-RM significantly outperforms existing baseline models and reveals conserved sequence patterns associated with RNA modification across evolutionary lineages. Together, these findings establish HiFormer-RM as a powerful tool for advancing the understanding of epi-transcriptomic regulation and provide a unified framework for multi-modification prediction across species.

 

 

Dr. Jingjing Liu
Hong Kong University of Science and Technology

 

Jingjing Liu received a Ph.D. in Environmental Science from the Hong Kong University of Science and Technology (HKUST) in 2016. After graduating from HKUST, she joined the Henry Lam Group at the department of biological and chemical engineering at HKUST, as a postdoctoral research scientist. There, she switched her research direction to proteomics and systems biology. Dr. Liu's research interests primarily focus on: 1. Gut microbiota and colorectal cancer, 2. Omics data analysis and mining, and 3. Mass spectrometry.

 

Speech Title: "Thioproline Modulates Gut Microbiota and Metabolism to Resist Colorectal Cancer"

 

Abstract: Colorectal cancer (CRC) ranks among the top three cancers globally in terms of incidence and mortality, and it is driven by an inflammatory environment in the gut, which can be induced by dysbiosis of the gut microbiome. Shaping gut microbiota community is proved effective in alleviate intestinal inflammation. Given the significant role of gut bacteria in the development of CRC, the ability of thioproline—a food bioactive—to modulate gut bacteria and resist CRC remains largely underexplored. To understand the effects of thioproline on gut microbiota community, we employed an integrated approach combining metagenomics and metabolomics to investigate the mechanisms through which thioproline regulates gut microbiota and exerts its anticancer effects. The metagenome and metabolome data reavled that thioproline treatment significantly changed gut miacrobiota community composition and metabolism in CRC. Our study reveals thioproline’s dual role in gut microbiota remodeling and metabolic regulation, leading to reduced CRC-associated inflammation. This study highlights its therapeutic potential in in modulating gut microbiota composition and metabolism to combat CRC, providing valuable insights for future studies and applications.

 

Dr. Jin Wang
Capital Medical University

 

Dr. Jin Wang received her Ph.D. in Physiology from Peking University in 2022 and is a researcher at Beijing Ditan Hospital, Capital Medical University. Her research focuses on mechanotransduction and cell–extracellular matrix (ECM) interactions in the development of cardiovascular disease. Her research aims to identify mechanosensitive cell populations and to elucidate the molecular mechanisms by which they contribute to cardiovascular disease. Her findings have been published in high-impact journals such as Bioactive Materials and Circulation Research. She was selected for the Youth Talent Support Program of the Beijing Association for Science and Technology.

 

 

Dr. Yaling Zhu
Anhui Medical University

 

Dr. Yaling Zhu is an Associate Professor in the Department of Pathophysiology at Anhui Medical University. She has appointed as visiting scholar at the University of Science and Technology of China and is a member of the Chinese Association of Pathophysiology. Her main research focuses on high-throughput multi-omics data analysis and epigenomics, with particular interest in the epigenetic regulatory mechanisms of metabolic dysfunction-associated steatotic liver disease (MASLD). She has authored over 20 papers as a corresponding or first author in prestigious journals such as ACS Nano (Q1 Top, IF=17.1), Advanced Science (Q1 Top, IF=14.3), Journal of Experimental & Clinical Cancer Research (Q1, IF=12.8) and holds three patents. She has led eight research projects at the national, provincial, and university levels, including National Natural Science Foundation of China and provincial scientific funds. In addition to her research achievements, she has been recognized as the lead instructor for a national high-quality online course on medical teacher development. She has also been honored with awards such as the "Famous Teaching Master in Curriculum Ideology and Politics," the national "Outstanding Advisor" award in the National College Students’ Innovation in Basic Medical Research contest, and the title of "Outstanding Class Advisor.

 

Speech Title: "Epigenetic Activation of TDO2 by H3K27ac Promotes Hepatic Steatosis via M1 Macrophage Polarization"

 

Abstract: H3K27ac has been widely recognized as a representative epigenetic marker of active enhancer. However, the critical role and detailed regulatory mechanisms of H3K27ac in the pathogenesis of MASLD remain elusive. Here, we performed a genome-wide comparative study on H3K27ac activities and the corresponding mRNA profiling in high fat diet (HFD)-induced MASLD model. A significantly enhanced H3K27ac density with abundant alterations of regulatory transcriptome was observed in the liver of MASLD rats. Based on integrative analysis of ChIP-Seq and RNA-Seq, TDO2 was identified as a critical contributor for abnormal lipid accumulation, which was transcriptionally activated by YY1-promoted H3K27ac modification. Further, depletion of TDO2 effectively protected against hepatic steatosis both in vivo and in vitro. In terms of mechanisms, we demonstrated TDO2 activated KYN/AHR/NF-κB pathway to promote macrophages M1 polarization, representing an crucial event in driving MASLD progression. Motivated by these findings, a bovine serum albumin (BSA) nanoparticles (NPs) was fabricated to provide sustained release of Allopurinol (NPs-Allo) for TDO2 inhibition, possessing excellent biocompatibility and desired targeting capacity. Venous injection of NPs-Allo robustly alleviated HFD-induced metabolic disorders. This study reveals the pivotal role of TDO2 and its underlying mechanisms in pathogenesis of MASLD from both epigenetical and genetical levels. Targeting H3K27ac-TDO2-NF-κB axis may provide new insights into the pathogenesis of abnormal lipid accumulation and pave the way for developing novel strategies for MASLD prevention and treatment.

 

 

Assist. Prof. Yinran Chen
Xiamen University

 

Dr. Yinran Chen received his B.S. and Ph.D. degrees (Hons.) in Biomedical Engineering from Tsinghua University, China, in 2014 and 2019, respectively. He joined the Cardiovascular Imaging and Dynamics Laboratory, University of Leuven (KU Leuven), Belgium, as a Visiting Scholar in 2015. He is currently with the Department of Computer Science and Technology, School of Informatics, Xiamen University an assistant professor. He was supported by the Young Scientists Fund from the National Natural Science Foundation of China and the Excellent Young Scientists Fund from the Fujian Provincial Natural Science Foundation of China. He is a member of the Technical Program Committee (TPC) of IEEE International Ultrasonics Symposium (IUS) and a committee member of the Medical Imaging Computing Seminar (MICS). His research interests include ultrasound beamforming, ultrasound blood flow imaging, volumetric ultrasound imaging, and medical image processing.

 

Speech Title: "Advances in Ultrasound Microvascular Imaging and its Application"

 

Abstract: Vascular imaging with color and power Doppler is a useful tool in the assessment of various disease processes. Assessment of blood flow, from infarction and ischemia to hyperemia, in organs, neoplasms, and vessels, is used in nearly every US investigation. Recent developments in this area are sensitive to small-vessel low velocity flow, known as microvascular flow imaging (MVFI). MVFI is more sensitive in the detection of small vessels than color, power, and spectral Doppler. Varying clinical applications of MVFI are reviewed in adult and pediatric populations, including its technical underpinnings. MVFI shows promise in the assessment of several conditions, including benign and malignant lesions in the liver and kidney, acute pathologic abnormalities in the gallbladder and testes, and superficial lymph nodes. This talk presents recent technical advances from our group, focusing on spatiotemporal clutter filtering, micro vector flow imaging, and artificial intelligence-assisted microvascular imaging.

 

Assist. Prof.  Fei Qi
Xiamen University

 

Qi Fei, Assistant Professor at the School of Life Sciences, Xiamen University. He holds a PhD in Bioinformatics from Technical University of Munich. He is recognized as a High-Level Talent of Fujian Province and a High-Level Talent of Xiamen City. His research focuses on the regulation of translational elongation and functional elements of non-coding RNAs. In recent years, he has published numerous research papers as first author or corresponding author in journals such as Nature Chemical Biology, Nucleic Acids Research, Genomics, Proteomics & Bioinformatics, Nucleic Acids Research, Communications Biology and etc.

 

Speech Title: "Regulation of the Translational Elongation Process"

 

Abstract: The translational elongation process is a key step in gene expression. It not only affects the yield of proteins encoded by genes but also regulates the quality control of protein synthesis. The translational elongation process is controlled by multiple translational elongation factors and cis-acting elements. These regulatory elements are located at different levels of genetic information and act on different steps of translational elongation, thereby co-regulating the translational elongation process. Through experiments and multi-omics data analysis, our work has investigated the regulatory roles of multiple translational elongation factors and cis-regulatory elements in the translational elongation process. Furthermore, we have clarified the interaction patterns of these elements in translational elongation at multiple scales, as well as their regulatory mechanisms in gene expression and protein synthesis quality control.

 

 

 

 

Previous Speakers

 

Prof. Yuan-Ting Zhang City University of Hongkong	Prof. Alexander Suvoror Institute of Experimental Medicine, St. Petersburg	Prof. David Zhang The Chinese University of Hongkong, China (Shenzhen)
Prof.Tun-Wen Pai National Taipei University of Technology	Prof. Dong-Qing Wei Shanghai Jiaotong University	Prof. TSUI Kwok-Wing Stephen The Chinese University of Hongkong
Prof. Cathy Wu University of Delaware	Prof. Xuegong Zhang Tsinghua University	Prof. Yi Pan Chinese Academy of Sciences
Prof. Bairong Shen Sichuan University	Prof. Wing-Kin Sung The Chinese University of Hongkong, and Hongkong Genome Institute	Prof. Chanchal Mitra University of Hyderabad
Assoc. Prof. Jie Zheng ShanghaiTech University	Prof. Peiyu Zhang Henan University	Prof. Zheng Zhou Chinese Academy of Sciences
Prof. Le Zhang Sichuan University	Prof. Fei Guo Central South University	Prof. Bin Liu Beijing Institute of Technology
Mr. Xiaoqiang Li China National GeneBank DataBase	Prof. Guan Ning Lin Shanghai Jiao Tong University	Assoc. Prof. Hon-Cheong So The Chinese University of Hongkong
Prof. Limsoon Wong (ACM Fellow) National University of Singapore	Prof. Bing Zhang Shanghai Jiao Tong University	Prof. An-Yuan Guo West China Hospital, Sichuan University
Prof. Pui-Chi Gigi Lo City University of Xiamen	Asst. Prof. Mengsha Tong Xiamen University	Prof. Jose Nacher Toho University
Prof. Rongshan Yu(SMIEEE, FIET) Vice Director, National Institute for Data Science in Health and Medicine, Xiamen University	Prof. Yasukazu Nakamura (H-index: 66) National Institute of Genetics	Prof. Xiaopei Shen Fujian Medical University